Safety	B:C1705187
of	O
transradial	O
diagnostic	O
cardiac	O
catheterization	O
in	O
patients	O
under	O
oral	O
anticoagulant	O
therapy	I:C0150457
Cardiac	O
catheterization	I:C0018795
in	O
anticoagulated	O
patients	O
is	O
usually	O
performed	O
after	O
the	O
anticoagulation	O
has	O
been	O
withdrawn	O
,	O
at	O
least	O
in	O
the	O
previous	O
48h	O
,	O
and	O
sometimes	O
bridging	O
therapy	I:C3873426
with	I:C3873426
heparin	I:C3873426
is	O
used	O
.	O

Safety	O
of	O
transradial	O
diagnostic	O
cardiac	O
catheterization	O
in	O
patients	O
under	O
oral	B:C0442027
anticoagulant	O
therapy	I:C0150457
Cardiac	O
catheterization	I:C0018795
in	O
anticoagulated	O
patients	O
is	O
usually	O
performed	O
after	O
the	O
anticoagulation	O
has	O
been	O
withdrawn	O
,	O
at	O
least	O
in	O
the	O
previous	O
48h	O
,	O
and	O
sometimes	O
bridging	O
therapy	I:C3873426
with	I:C3873426
heparin	I:C3873426
is	O
used	O
.	O

Safety	O
of	O
transradial	O
diagnostic	O
cardiac	O
catheterization	O
in	O
patients	O
under	O
oral	O
anticoagulant	B:C0150457
therapy	I:C0150457
Cardiac	O
catheterization	I:C0018795
in	O
anticoagulated	O
patients	O
is	O
usually	O
performed	O
after	O
the	O
anticoagulation	O
has	O
been	O
withdrawn	O
,	O
at	O
least	O
in	O
the	O
previous	O
48h	O
,	O
and	O
sometimes	O
bridging	O
therapy	I:C3873426
with	I:C3873426
heparin	I:C3873426
is	O
used	O
.	O

Safety	O
of	O
transradial	O
diagnostic	O
cardiac	O
catheterization	O
in	O
patients	O
under	O
oral	O
anticoagulant	O
therapy	I:C0150457
Cardiac	B:C0018795
catheterization	I:C0018795
in	O
anticoagulated	O
patients	O
is	O
usually	O
performed	O
after	O
the	O
anticoagulation	O
has	O
been	O
withdrawn	O
,	O
at	O
least	O
in	O
the	O
previous	O
48h	O
,	O
and	O
sometimes	O
bridging	O
therapy	I:C3873426
with	I:C3873426
heparin	I:C3873426
is	O
used	O
.	O

Safety	O
of	O
transradial	O
diagnostic	O
cardiac	O
catheterization	O
in	O
patients	O
under	O
oral	O
anticoagulant	O
therapy	I:C0150457
Cardiac	O
catheterization	I:C0018795
in	O
anticoagulated	O
patients	O
is	O
usually	O
performed	O
after	O
the	O
anticoagulation	B:C0003281
has	O
been	O
withdrawn	O
,	O
at	O
least	O
in	O
the	O
previous	O
48h	O
,	O
and	O
sometimes	O
bridging	O
therapy	I:C3873426
with	I:C3873426
heparin	I:C3873426
is	O
used	O
.	O

Safety	O
of	O
transradial	O
diagnostic	O
cardiac	O
catheterization	O
in	O
patients	O
under	O
oral	O
anticoagulant	O
therapy	I:C0150457
Cardiac	O
catheterization	I:C0018795
in	O
anticoagulated	O
patients	O
is	O
usually	O
performed	O
after	O
the	O
anticoagulation	O
has	O
been	O
withdrawn	B:C1707825
,	O
at	O
least	O
in	O
the	O
previous	O
48h	O
,	O
and	O
sometimes	O
bridging	O
therapy	I:C3873426
with	I:C3873426
heparin	I:C3873426
is	O
used	O
.	O

Safety	O
of	O
transradial	O
diagnostic	O
cardiac	O
catheterization	O
in	O
patients	O
under	O
oral	O
anticoagulant	O
therapy	I:C0150457
Cardiac	O
catheterization	I:C0018795
in	O
anticoagulated	O
patients	O
is	O
usually	O
performed	O
after	O
the	O
anticoagulation	O
has	O
been	O
withdrawn	O
,	O
at	O
least	O
in	O
the	O
previous	O
48h	O
,	O
and	O
sometimes	O
bridging	B:C3873426
therapy	I:C3873426
with	I:C3873426
heparin	I:C3873426
is	O
used	O
.	O

A	O
prospective	O
observational	B:C1518527
study	I:C1518527
including	O
489	O
patients	O
undergoing	O
transradial	O
catheterization	I:C0018795
was	O
conducted	O
.	O

A	O
prospective	O
observational	O
study	I:C1518527
including	O
489	O
patients	O
undergoing	O
transradial	B:C0018795
catheterization	I:C0018795
was	O
conducted	O
.	O

A	O
total	O
of	O
140	O
patients	O
were	O
under	O
acenocoumarol	B:C0000956
(	O
group	O
A	I:C0441835
)	O
and	O
they	O
were	O
compared	O
with	O
the	O
remainder	O
(	O
group	O
B	I:C0441836
)	O
for	O
complications	O
after	O
the	O
procedure	O
(	O
bleeding	O
and	O
vascular	O
access	I:C0920165
complications	I:C0920165
)	O
.	O

A	O
total	O
of	O
140	O
patients	O
were	O
under	O
acenocoumarol	O
(	O
group	B:C0441835
A	I:C0441835
)	O
and	O
they	O
were	O
compared	O
with	O
the	O
remainder	O
(	O
group	O
B	I:C0441836
)	O
for	O
complications	O
after	O
the	O
procedure	O
(	O
bleeding	O
and	O
vascular	O
access	I:C0920165
complications	I:C0920165
)	O
.	O

A	O
total	O
of	O
140	O
patients	O
were	O
under	O
acenocoumarol	O
(	O
group	O
A	I:C0441835
)	O
and	O
they	O
were	O
compared	O
with	O
the	O
remainder	O
(	O
group	B:C0441836
B	I:C0441836
)	O
for	O
complications	O
after	O
the	O
procedure	O
(	O
bleeding	O
and	O
vascular	O
access	I:C0920165
complications	I:C0920165
)	O
.	O

A	O
total	O
of	O
140	O
patients	O
were	O
under	O
acenocoumarol	O
(	O
group	O
A	I:C0441835
)	O
and	O
they	O
were	O
compared	O
with	O
the	O
remainder	O
(	O
group	O
B	I:C0441836
)	O
for	O
complications	B:C0009566
after	O
the	O
procedure	O
(	O
bleeding	O
and	O
vascular	O
access	I:C0920165
complications	I:C0920165
)	O
.	O

A	O
total	O
of	O
140	O
patients	O
were	O
under	O
acenocoumarol	O
(	O
group	O
A	I:C0441835
)	O
and	O
they	O
were	O
compared	O
with	O
the	O
remainder	O
(	O
group	O
B	I:C0441836
)	O
for	O
complications	O
after	O
the	O
procedure	B:C0018795
(	O
bleeding	O
and	O
vascular	O
access	I:C0920165
complications	I:C0920165
)	O
.	O

A	O
total	O
of	O
140	O
patients	O
were	O
under	O
acenocoumarol	O
(	O
group	O
A	I:C0441835
)	O
and	O
they	O
were	O
compared	O
with	O
the	O
remainder	O
(	O
group	O
B	I:C0441836
)	O
for	O
complications	O
after	O
the	O
procedure	O
(	O
bleeding	B:C0019080
and	O
vascular	O
access	I:C0920165
complications	I:C0920165
)	O
.	O

A	O
total	O
of	O
140	O
patients	O
were	O
under	O
acenocoumarol	O
(	O
group	O
A	I:C0441835
)	O
and	O
they	O
were	O
compared	O
with	O
the	O
remainder	O
(	O
group	O
B	I:C0441836
)	O
for	O
complications	O
after	O
the	O
procedure	O
(	O
bleeding	O
and	O
vascular	B:C0920165
access	I:C0920165
complications	I:C0920165
)	O
.	O

Patients	O
in	O
group	B:C0441835
A	I:C0441835
were	O
older	O
(	O
74±12	O
years	O
vs.	O
68±17	O
years	O
,	O
p<0.01	O
)	O
and	O
the	O
main	O
indication	O
for	O
anticoagulation	O
was	O
atrial	O
fibrillation	I:C0004238
(	O
58.6	O
%	O
)	O
.	O

Patients	O
in	O
group	O
A	I:C0441835
were	O
older	B:C1518563
(	O
74±12	O
years	O
vs.	O
68±17	O
years	O
,	O
p<0.01	O
)	O
and	O
the	O
main	O
indication	O
for	O
anticoagulation	O
was	O
atrial	O
fibrillation	I:C0004238
(	O
58.6	O
%	O
)	O
.	O

Patients	O
in	O
group	O
A	I:C0441835
were	O
older	O
(	O
74±12	O
years	O
vs.	O
68±17	O
years	O
,	O
p<0.01	O
)	O
and	O
the	O
main	O
indication	O
for	O
anticoagulation	B:C0003281
was	O
atrial	O
fibrillation	I:C0004238
(	O
58.6	O
%	O
)	O
.	O

Patients	O
in	O
group	O
A	I:C0441835
were	O
older	O
(	O
74±12	O
years	O
vs.	O
68±17	O
years	O
,	O
p<0.01	O
)	O
and	O
the	O
main	O
indication	O
for	O
anticoagulation	O
was	O
atrial	B:C0004238
fibrillation	I:C0004238
(	O
58.6	O
%	O
)	O
.	O

No	B:C1513916
complications	O
occurred	O
during	O
the	O
procedures	O
.	O

No	O
complications	B:C0009566
occurred	O
during	O
the	O
procedures	O
.	O

No	O
complications	O
occurred	O
during	O
the	O
procedures	B:C0018795
.	O

There	O
were	O
no	B:C1513916
acute	O
bleedings	I:C0333276
just	O
after	O
the	O
bandage	O
removal	O
.	O

There	O
were	O
no	O
acute	B:C0333276
bleedings	I:C0333276
just	O
after	O
the	O
bandage	O
removal	O
.	O

There	O
were	O
no	O
acute	O
bleedings	I:C0333276
just	O
after	O
the	O
bandage	B:C0004726
removal	O
.	O

During	O
the	O
first	O
24h	O
,	O
only	O
3	O
(	O
2.1	O
%	O
)	O
radial	B:C1110554
occlusions	I:C1110554
in	O
group	O
A	I:C0441835
and	O
2	O
(	O
0.6	O
%	O
)	O
in	O
group	O
B	I:C0441836
(	O
p=0.14	O
)	O
were	O
recorded	O
.	O

During	O
the	O
first	O
24h	O
,	O
only	O
3	O
(	O
2.1	O
%	O
)	O
radial	O
occlusions	I:C1110554
in	O
group	B:C0441835
A	I:C0441835
and	O
2	O
(	O
0.6	O
%	O
)	O
in	O
group	O
B	I:C0441836
(	O
p=0.14	O
)	O
were	O
recorded	O
.	O

During	O
the	O
first	O
24h	O
,	O
only	O
3	O
(	O
2.1	O
%	O
)	O
radial	O
occlusions	I:C1110554
in	O
group	O
A	I:C0441835
and	O
2	O
(	O
0.6	O
%	O
)	O
in	O
group	B:C0441836
B	I:C0441836
(	O
p=0.14	O
)	O
were	O
recorded	O
.	O

Hematomas	B:C0018944
between	O
5	O
and	O
10	O
cm	O
appeared	O
in	O
5	O
%	O
of	O
the	O
group	O
A	I:C0441835
vs.	O
4.6	O
%	O
in	O
group	O
B	I:C0441836
.	O
During	O
the	O
1	O
-	O
month	O
follow	O
-	I:C1522577
up	I:C1522577
period	O
,	O
one	O
more	O
radial	O
occlusion	I:C1110554
in	O
each	O
group	O
was	O
recorded	O
and	O
there	O
were	O
4	O
(	O
1.1	O
%	O
)	O
additional	O
mild	O
hematomas	O
in	O
group	O
B	I:C0441836
and	O
none	O
in	O
group	O
A	I:C0441835
(	O
p=0.48	O
)	O
.	O

Hematomas	O
between	O
5	O
and	O
10	O
cm	O
appeared	O
in	O
5	O
%	O
of	O
the	O
group	B:C0441835
A	I:C0441835
vs.	O
4.6	O
%	O
in	O
group	O
B	I:C0441836
.	O
During	O
the	O
1	O
-	O
month	O
follow	O
-	I:C1522577
up	I:C1522577
period	O
,	O
one	O
more	O
radial	O
occlusion	I:C1110554
in	O
each	O
group	O
was	O
recorded	O
and	O
there	O
were	O
4	O
(	O
1.1	O
%	O
)	O
additional	O
mild	O
hematomas	O
in	O
group	O
B	I:C0441836
and	O
none	O
in	O
group	O
A	I:C0441835
(	O
p=0.48	O
)	O
.	O

Hematomas	O
between	O
5	O
and	O
10	O
cm	O
appeared	O
in	O
5	O
%	O
of	O
the	O
group	O
A	I:C0441835
vs.	O
4.6	O
%	O
in	O
group	B:C0441836
B	I:C0441836
.	O
During	O
the	O
1	O
-	O
month	O
follow	O
-	I:C1522577
up	I:C1522577
period	O
,	O
one	O
more	O
radial	O
occlusion	I:C1110554
in	O
each	O
group	O
was	O
recorded	O
and	O
there	O
were	O
4	O
(	O
1.1	O
%	O
)	O
additional	O
mild	O
hematomas	O
in	O
group	O
B	I:C0441836
and	O
none	O
in	O
group	O
A	I:C0441835
(	O
p=0.48	O
)	O
.	O

Hematomas	O
between	O
5	O
and	O
10	O
cm	O
appeared	O
in	O
5	O
%	O
of	O
the	O
group	O
A	I:C0441835
vs.	O
4.6	O
%	O
in	O
group	O
B	I:C0441836
.	O
During	O
the	O
1	O
-	O
month	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
period	O
,	O
one	O
more	O
radial	O
occlusion	I:C1110554
in	O
each	O
group	O
was	O
recorded	O
and	O
there	O
were	O
4	O
(	O
1.1	O
%	O
)	O
additional	O
mild	O
hematomas	O
in	O
group	O
B	I:C0441836
and	O
none	O
in	O
group	O
A	I:C0441835
(	O
p=0.48	O
)	O
.	O

Hematomas	O
between	O
5	O
and	O
10	O
cm	O
appeared	O
in	O
5	O
%	O
of	O
the	O
group	O
A	I:C0441835
vs.	O
4.6	O
%	O
in	O
group	O
B	I:C0441836
.	O
During	O
the	O
1	O
-	O
month	O
follow	O
-	I:C1522577
up	I:C1522577
period	O
,	O
one	O
more	O
radial	B:C1110554
occlusion	I:C1110554
in	O
each	O
group	O
was	O
recorded	O
and	O
there	O
were	O
4	O
(	O
1.1	O
%	O
)	O
additional	O
mild	O
hematomas	O
in	O
group	O
B	I:C0441836
and	O
none	O
in	O
group	O
A	I:C0441835
(	O
p=0.48	O
)	O
.	O

Hematomas	O
between	O
5	O
and	O
10	O
cm	O
appeared	O
in	O
5	O
%	O
of	O
the	O
group	O
A	I:C0441835
vs.	O
4.6	O
%	O
in	O
group	O
B	I:C0441836
.	O
During	O
the	O
1	O
-	O
month	O
follow	O
-	I:C1522577
up	I:C1522577
period	O
,	O
one	O
more	O
radial	O
occlusion	I:C1110554
in	O
each	O
group	O
was	O
recorded	O
and	O
there	O
were	O
4	O
(	O
1.1	O
%	O
)	O
additional	O
mild	O
hematomas	B:C0018944
in	O
group	O
B	I:C0441836
and	O
none	O
in	O
group	O
A	I:C0441835
(	O
p=0.48	O
)	O
.	O

Hematomas	O
between	O
5	O
and	O
10	O
cm	O
appeared	O
in	O
5	O
%	O
of	O
the	O
group	O
A	I:C0441835
vs.	O
4.6	O
%	O
in	O
group	O
B	I:C0441836
.	O
During	O
the	O
1	O
-	O
month	O
follow	O
-	I:C1522577
up	I:C1522577
period	O
,	O
one	O
more	O
radial	O
occlusion	I:C1110554
in	O
each	O
group	O
was	O
recorded	O
and	O
there	O
were	O
4	O
(	O
1.1	O
%	O
)	O
additional	O
mild	O
hematomas	O
in	O
group	B:C0441836
B	I:C0441836
and	O
none	O
in	O
group	O
A	I:C0441835
(	O
p=0.48	O
)	O
.	O

Hematomas	O
between	O
5	O
and	O
10	O
cm	O
appeared	O
in	O
5	O
%	O
of	O
the	O
group	O
A	I:C0441835
vs.	O
4.6	O
%	O
in	O
group	O
B	I:C0441836
.	O
During	O
the	O
1	O
-	O
month	O
follow	O
-	I:C1522577
up	I:C1522577
period	O
,	O
one	O
more	O
radial	O
occlusion	I:C1110554
in	O
each	O
group	O
was	O
recorded	O
and	O
there	O
were	O
4	O
(	O
1.1	O
%	O
)	O
additional	O
mild	O
hematomas	O
in	O
group	O
B	I:C0441836
and	O
none	O
in	O
group	B:C0441835
A	I:C0441835
(	O
p=0.48	O
)	O
.	O

Performing	O
a	O
transradial	O
diagnostic	O
cardiac	O
catheterization	O
without	O
removal	O
of	O
the	O
oral	B:C0442027
chronic	O
anticoagulation	O
appears	O
safe	O
in	O
patients	O
under	O
acenocumarol	O
therapy	O
.	O

Performing	O
a	O
transradial	O
diagnostic	O
cardiac	O
catheterization	O
without	O
removal	O
of	O
the	O
oral	O
chronic	O
anticoagulation	O
appears	O
safe	B:C3266157
in	O
patients	O
under	O
acenocumarol	O
therapy	O
.	O

Performing	O
a	O
transradial	O
diagnostic	O
cardiac	O
catheterization	O
without	O
removal	O
of	O
the	O
oral	O
chronic	O
anticoagulation	O
appears	O
safe	O
in	O
patients	O
under	O
acenocumarol	B:C0000956
therapy	O
.	O

Performing	O
a	O
transradial	O
diagnostic	O
cardiac	O
catheterization	O
without	O
removal	O
of	O
the	O
oral	O
chronic	O
anticoagulation	O
appears	O
safe	O
in	O
patients	O
under	O
acenocumarol	O
therapy	B:C0087111
.	O

